Clinical trial

Masitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple Sclerosis

NCT01450488

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-06-01

PhasePHASE2

Study timeline

Study start (unknown)2005-06-01Date precision: month

Registry last updated2018-12-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

masitinibDRUG

Sponsors & collaborators

AB Sciencelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01450488 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.